Quantinuum prices IPO at $60 per share, raising $1.68 billion
In brief
- Quantinuum priced 28 million shares at $60 each, exceeding its $53-$55 initial range.
- IPO raised $1.68 billion, surpassing the $1.05 billion target by more than 60%.
- Company began trading under ticker QNT on Nasdaq Global Market on June 4.
- Quantinuum will receive $100 million from the US government's $2 billion quantum initiative.
- IPO adds approximately 56% to the company's September 2025 valuation of $10 billion.
IPO Oversubscription Signals Investor Appetite
Quantinuum priced 28 million shares at $60 each, exceeding its initial fundraising target of $1.05 billion by more than 60%. The final pricing landed above the initial range of $53 to $55 per share, reflecting robust institutional demand.
The offering marks a significant milestone for the quantum computing sector. IonQ, Rigetti Computing, and D-Wave Quantum are all publicly traded, but Quantinuum's traditional IPO structure and scale set it apart from earlier quantum entrants.
Path to Public Markets
Quantinuum's journey to the public markets accelerated over the past two years. The company raised a $300 million round at a $5 billion pre-money valuation, then completed a $600 million private funding round in September 2025 at a $10 billion valuation. The IPO effectively added another 56% on top of that September figure.
Honeywell brought the hardware expertise and trapped-ion quantum processors to the 2021 merger, while Cambridge Quantum contributed software and algorithm capabilities. That combination has positioned the company as a vertically integrated player in quantum hardware and software development.
Government Support Bolsters Capital Position
Timing worked in Quantinuum's favor. On May 21, roughly two weeks before pricing, the US government announced a $2 billion quantum initiative. Quantinuum is set to receive $100 million from that program.
Combined with IPO proceeds, that $1.68 billion war chest, plus the $100 million in federal funding, gives Quantinuum roughly $1.78 billion in fresh capital. The capital infusion arrives as quantum computing moves from research labs into commercial applications across pharmaceuticals, materials science, and optimization problems.
The IPO success suggests institutional investors see quantum computing as a maturing sector worth backing at scale, not just a speculative bet on future technology.
